West Herts tenders for a new cancer information system

  • 3 October 2017
West Herts tenders for a new cancer information system

West Hertfordshire Hospitals NHS Trust is looking to replace its cancer information system.

The West Herts Macmillan Cancer Information Centre is currently using Chameleon IMS, supplied by Infloflex, which it deployed back in 2009 – according to Digital Health Intelligence data. With the contract due to expire in March next year, it is exploring opportunities for a new system.

The centre which provides vital information and support and for anyone living with cancer, their relatives and friends, is seeking a system which will enable compliance with the data collection and reporting and submission requirements for all aspects of cancer information. This includes national cancer audits, Cancer Waiting Times and COSD.

In its tender documents, the trust outlined that the system must also support real-time and complete monitoring and tracking of patients in MDT meetings.

“The system must enable the production of outcome reports in a format that can be shared with clinical colleagues including to the referrer as appropriate.”

“The system must be capable of interfacing with internal systems including the patient administration system and sharing documents with the Trust’s clinical portal’.”

West Hertfordshire trust provides hospital services to 550,000 people living in Hertfordshire and north London. It is one of the largest employers locally, with about 4,400 staff and 446 volunteers. Services are run across three sites at Watford, St Albans and Hemel Hempstead.

Its cancer centre has been funded by Macmillan Cancer Support and developed in partnership with West Hertfordshire trust and Grove House. It is run by Macmillan patient information manager Fiona McNaband supported by trained volunteers.

The Centre sees about 2,500 patients a year with a diagnosis of cancer and is planning to enter into a five-year contract for the new cancer information system.

Subscribe to our newsletter

Subscribe To Our Newsletter

Subscribe To Our Newsletter

Sign up

Related News

Government launches AI breast cancer trial

Government launches AI breast cancer trial

The government has announced the launch of a trial that will test how AI tools can be used to detect cases of breast cancer earlier.
Online hub launched to help patients understand Lynch Syndrome

Online hub launched to help patients understand Lynch Syndrome

Airedale and Bradford hospitals have teamed together to create and launch a digital resource for patients on diagnosing Lynch Syndrome.
Funding announced to boost development of health tech for cancer

Funding announced to boost development of health tech for cancer

New medical technologies to diagnose cancer, such as scanners and AI models, will be trialled in the UK following new government funding.

1 Comments

  • A PERSON’s unique cancer pathway(s) will (probably) be some of the most complex pathways making up their health journey. It is possible that the PERSON will be waiting for concurrent treatments i.e. multiple Referral To Treatment Period timers running at the same time. I hope the new system will be able to manage such complexities, best to look at the underlying DATA model behind the contenders offerings.

Comments are closed.